Akums Drugs and Pharmaceuticals Limited

NSEI:AKUMS Stock Report

Market Cap: ₹125.9b

Akums Drugs and Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of AKUMS?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme4,291,9302.73%
General Public9,965,2276.33%
Individual Insiders57,328,88036.4%
Private Companies85,784,97054.5%

Dilution of Shares: AKUMS only recently listed within the past 12 months


Top Shareholders

Top 5 shareholders own 93.67% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
40.8%
Akums Master Trust
64,200,000₹51.3b0%no data
18.2%
Sanjeev Jain
28,678,190₹22.9b-52.8%no data
18.2%
Sandeep Jain
28,650,690₹22.9b-52.8%no data
13.7%
Ruby QC Investment Holdings Pte. Ltd.
21,584,970₹17.3b0%no data
2.73%
Akums Employee Benefits Trust
4,291,930₹3.4b0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.